Welcome to CSNpharm! For Research Use Only!

HIV Integrase

HIV Integrase

Cat. No. Product Name CAS No. Information
CSN12254 Raltegravir potassium   871038-72-1 Raltegravir Potassium is an HIV integrase strand transfer inhibitor which acts as the first of the class of antiviral agents active against the human immunodeficiency virus (HIV).
CSN12253 Raltegravir   518048-05-0 Raltegravir is a potent integrase IN inhibitor for WT and S217Q PFV IN with IC50 of 90 nM and 40 nM in cell-free assays respectively It shows greater than 1000-fold selectivity for HIV-1 IN over several related Mg2-dependent enzyme such as HCV polymerase HIV reverse transcriptase HIV RNaseH and human - - -polymerases
CSN16815 MK-2048 869901-69-9 MK-2048 is a potent inhibitor of integrase and INR263K with IC50 of 26 nM and 15 nM respectively
CSN18639 LEDGIN6 957890-42-5 HIV-1 integrase inhibitor in the treatment of human immunodeficiency virus HIV infection
CSN22210 HIV-1 integrase inhibitor 4 1638504-66-1 HIV-1 integrase inhibitor 4 is a HIV-1 integrase strand transfer INST inhibitor with an IC50 of 37 nM
CSN22211 HIV-1 integrase inhibitor 3 1638504-56-9 HIV-1 integrase inhibitor 3 is a HIV-1 integrase strand transfer INST inhibitor with an IC50 of 27 nM
CSN12955 Elvitegravir   697761-98-1 Elvitegravir is a quinolinemonocarboxylic-acid HIV-1 integrase strand transfer inhibitor used to treat HIV infection. It is also a cytochrome P450 2C9 inducer.
CSN15749 Dolutegravir sodium   1051375-19-9 Dolutegravir sodium is an HIV integrase inhibitor IC50 27 nM with modest activity against raltegravir-resistant signature mutants Y143R Q148K N155H and G140SQ148H
CSN13497 Dolutegravir   1051375-16-6 Dolutegravir is an integrase inhibitor (IC50 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140SQ148H.
CSN10610 Chicoric acid 6537-80-0 Cichoric Acid is a naturally occuring phenylpropanoid found in a variety of plants used as an HIV Integrase inhibitor
CSN16297 Cabotegravir   1051375-10-0 Cabotegravir is a potent HIV integrase inhibitor as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV infection. Cabotegravir is an inhibitor of OAT1 (IC50 0.81 M) and OAT3 (IC50 0.41 M).
CSN18409 BMS-707035 729607-74-3 BMS-707035 is a potent specific reversible HIV-I integrase inhibitor with IC50 value of 15 nM
CSN16972 Bms-538203 543730-41-2 BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent
CSN20343 Bictegravir 1611493-60-7 Bictegravir is a potent, unboosted, once-Daily HIV-1 Integrase Strand Transfer inhibitor (INSTI) (IC50 - 1.6 nM) with improved pharmacokinetics and in vitro resistance profile.
CSN17501 BI 224436 1155419-89-8 BI-224436 is an HIV-1 noncatalytic site integrase inhibitor with EC50 values of less than 15 nM against different HIV-1 laboratory strains
CSN17820 (±)-BI-D 1416258-16-6 -BI-D is a potent ALLINI An allosteric IN inhibitor that binds integrase at the LEDGFp75 binding site
CSN84076 Cabotegravir sodium 1051375-13-3
<< PREV 1 NEXT >>